Previous studies have illustrated that ChREBP, also known as Mlxipl, is upregulated in diabetes and responsible for β-cell apoptosis and loss of β-cell mass (Jing et al. 2016; Katz et al. 2022). The gene discussed is MLXIPL; the disease is diabetes mellitus.